Brief: Genfit Outlines Anticipated New Clinical Trial Initiations, Development Milestones And Data Readouts In 2025
Feb 6 (Reuters) - Genfit SA GNFT.PA :
* GENFIT OUTLINES ANTICIPATED NEW CLINICAL TRIAL
INITIATIONS,
DEVELOPMENT MILESTONES AND DATA READOUTS IN 2025
* GENFIT SA: 2 NEW ACLF CLINICAL TRIALS EXPECTED TO INITIATE
IN
1Q25
* GENFIT SA: 3 CLINICAL DATA READOUTS EXPECTED BY YEAR-END
2025
ACROSS ACLF PIPELINE
Source text: ID:nGNXK8zpc
Further company coverage: GNFT.PA
((reuters.briefs@thomsonreuters.com;))
Recent news on Genfit SA
See all newsFrance's Genfit H1 revenue falls due to absence of milestone payments
French and Benelux stocks-Factors to watch on September 15
Brief: Genfit SA - Advances Nangibotide In Phase 2 Clinical Investigation In Aclf
Brief: Euronext Includes Genfit, Inventiva In SBF120 Index; Interparfums, Verallia Excluded
Brief: Genfit March 31 Cash And Cash Equivalents EUR 136.1 Million